Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands,…
Consensus price target: $2.00 (+20.48% upside from $1.66)
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2026 | $0 | — | $-16.72M |
| 2025 | $0 | — | $-11.41M |
| 2024 | $0 | — | $-15.43M |
Stock data for AMIX: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics